176 related articles for article (PubMed ID: 29065885)
1. Serum bilirubin and the risk of chronic obstructive pulmonary disease exacerbations.
Brown KE; Sin DD; Voelker H; Connett JE; Niewoehner DE; Kunisaki KM;
Respir Res; 2017 Oct; 18(1):179. PubMed ID: 29065885
[TBL] [Abstract][Full Text] [Related]
2. Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.
Leitao Filho FS; Ra SW; Mattman A; Schellenberg RS; Criner GJ; Woodruff PG; Lazarus SC; Albert R; Connett JE; Han MK; Martinez FJ; Leung JM; Paul Man SF; Aaron SD; Reed RM; Sin DD;
Respir Res; 2018 Feb; 19(1):30. PubMed ID: 29444682
[TBL] [Abstract][Full Text] [Related]
3. Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study.
Wetherbee EE; Niewoehner DE; Sisson JH; Lindberg SM; Connett JE; Kunisaki KM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1363-70. PubMed ID: 26229455
[TBL] [Abstract][Full Text] [Related]
4. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.
Han MK; Tayob N; Murray S; Dransfield MT; Washko G; Scanlon PD; Criner GJ; Casaburi R; Connett J; Lazarus SC; Albert R; Woodruff P; Martinez FJ
Am J Respir Crit Care Med; 2014 Jun; 189(12):1503-8. PubMed ID: 24779680
[TBL] [Abstract][Full Text] [Related]
5. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.
Kunisaki KM; Dransfield MT; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Hartley BF; Martinez FJ; Newby DE; Pragman AA; Vestbo J; Yates JC; Niewoehner DE;
Am J Respir Crit Care Med; 2018 Jul; 198(1):51-57. PubMed ID: 29442524
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study.
Kunisaki KM; Niewoehner DE; Connett JE;
Am J Respir Crit Care Med; 2012 Feb; 185(3):286-90. PubMed ID: 22077070
[TBL] [Abstract][Full Text] [Related]
7. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.
Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P
Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309
[TBL] [Abstract][Full Text] [Related]
10. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T
COPD; 2016; 13(2):139-45. PubMed ID: 26514682
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.
Bozinovski S; Hutchinson A; Thompson M; Macgregor L; Black J; Giannakis E; Karlsson AS; Silvestrini R; Smallwood D; Vlahos R; Irving LB; Anderson GP
Am J Respir Crit Care Med; 2008 Feb; 177(3):269-78. PubMed ID: 18006888
[TBL] [Abstract][Full Text] [Related]
13. Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients.
Erdal M; Johannessen A; Eagan TM; Bakke P; Gulsvik A; Grønseth R
Int J Chron Obstruct Pulmon Dis; 2016; 11():2099-108. PubMed ID: 27621614
[TBL] [Abstract][Full Text] [Related]
14. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
Moretti M; Fagnani S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
[TBL] [Abstract][Full Text] [Related]
15. Newly diagnosed gastroesophageal reflux disease increased the risk of acute exacerbation of chronic obstructive pulmonary disease during the first year following diagnosis--a nationwide population-based cohort study.
Lin YH; Tsai CL; Chien LN; Chiou HY; Jeng C
Int J Clin Pract; 2015 Mar; 69(3):350-7. PubMed ID: 25359162
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.
Ra SW; Sze MA; Lee EC; Tam S; Oh Y; Fishbane N; Criner GJ; Woodruff PG; Lazarus SC; Albert R; Connett JE; Han MK; Martinez FJ; Aaron SD; Reed RM; Man SFP; Sin DD;
Respir Res; 2017 May; 18(1):109. PubMed ID: 28558695
[TBL] [Abstract][Full Text] [Related]
17. The recent advances of phenotypes in acute exacerbations of COPD.
Zhou A; Zhou Z; Zhao Y; Chen P
Int J Chron Obstruct Pulmon Dis; 2017; 12():1009-1018. PubMed ID: 28392685
[TBL] [Abstract][Full Text] [Related]
18. Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis.
Leitao Filho FS; Mattman A; Schellenberg R; Criner GJ; Woodruff P; Lazarus SC; Albert RK; Connett J; Han MK; Gay SE; Martinez FJ; Fuhlbrigge AL; Stoller JK; MacIntyre NR; Casaburi R; Diaz P; Panos RJ; Cooper JA; Bailey WC; LaFon DC; Sciurba FC; Kanner RE; Yusen RD; Au DH; Pike KC; Fan VS; Leung JM; Man SP; Aaron SD; Reed RM; Sin DD
Chest; 2020 Oct; 158(4):1420-1430. PubMed ID: 32439504
[TBL] [Abstract][Full Text] [Related]
19. Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T.
Søyseth V; Bhatnagar R; Holmedahl NH; Neukamm A; Høiseth AD; Hagve TA; Einvik G; Omland T
Heart; 2013 Jan; 99(2):122-6. PubMed ID: 23024006
[TBL] [Abstract][Full Text] [Related]
20. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity].
Liu H; Xu JY
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
